Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea
Crossref DOI link: https://doi.org/10.1007/s00280-017-3462-y
Published Online: 2017-10-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Masab, Muhammad
Saif, Muhammad Wasif
License valid from 2017-10-19